Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4+T cell responses

Post time Yesterday 16:56

journal：Science Translational Medicine

Authors：Jillian M. Jespersen; Lia Avanesyan; Jean Publicover; Nicholas D. Carey; Ravi K. Patel; Austin W. Edwards; Sarah Stenske; Jae Shin; Jiajing Li; Margaret Simone; Nayvin W. Chew; Nicholas Wong; Suprita Trilok; Ann Erickson; Arjun Rao; Christopher P. Loo; Michael Stec; Mark Anderson; Gavin Cloherty; Monika Sarkar; Stephen L. Nishimura; Alexis J. Combes; Adil E. Wakil; Mark R. Segal; Gabriela K. Fragiadakis; Stewart L. Cooper; Jody L. Baron

Published date：2026-4-29

DOI：10.1126/scitranslmed.adx1523

PDF link：https://www.science.org/doi/pdf/10.1126/scitranslmed.adx1523

Article link：https://doi.org/10.1126/scitranslmed.adx1523

Article Source：American Association for the Advancement of Science (AAAS)。

Remark：

[AAAS] Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4+T cell responses

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AAAS] Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4+T cell responses Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AAAS] Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4+T cell responses